Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants

10.1177/0091270011407195

Saved in:

Bibliographic Details
Main Authors:	Willis, B.A., Zhang, W., Ayan-Oshodi, M., Lowe, S.L., Annes, W.F., Sirois, P.J., Friedrich, S., De La Peña, A.
Other Authors:	INSTITUTE OF MOLECULAR & CELL BIOLOGY
Format:	Article
Published:	2014
Subjects:	γ-secretase Alzheimer disease Semagacestat
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/112067
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-112067
record_format	dspace
spelling	sg-nus-scholar.10635-1120672024-11-11T01:13:56Z Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants Willis, B.A. Zhang, W. Ayan-Oshodi, M. Lowe, S.L. Annes, W.F. Sirois, P.J. Friedrich, S. De La Peña, A. INSTITUTE OF MOLECULAR & CELL BIOLOGY γ-secretase Alzheimer disease Semagacestat 10.1177/0091270011407195 Journal of Clinical Pharmacology 52 6 904-913 JCPCB 2014-11-28T02:52:49Z 2014-11-28T02:52:49Z 2012-06 Article Willis, B.A., Zhang, W., Ayan-Oshodi, M., Lowe, S.L., Annes, W.F., Sirois, P.J., Friedrich, S., De La Peña, A. (2012-06). Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants. Journal of Clinical Pharmacology 52 (6) : 904-913. ScholarBank@NUS Repository. https://doi.org/10.1177/0091270011407195 00912700 http://scholarbank.nus.edu.sg/handle/10635/112067 000304228900012 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	γ-secretase Alzheimer disease Semagacestat
spellingShingle	γ-secretase Alzheimer disease Semagacestat Willis, B.A. Zhang, W. Ayan-Oshodi, M. Lowe, S.L. Annes, W.F. Sirois, P.J. Friedrich, S. De La Peña, A. Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
description	10.1177/0091270011407195
author2	INSTITUTE OF MOLECULAR & CELL BIOLOGY
author_facet	INSTITUTE OF MOLECULAR & CELL BIOLOGY Willis, B.A. Zhang, W. Ayan-Oshodi, M. Lowe, S.L. Annes, W.F. Sirois, P.J. Friedrich, S. De La Peña, A.
format	Article
author	Willis, B.A. Zhang, W. Ayan-Oshodi, M. Lowe, S.L. Annes, W.F. Sirois, P.J. Friedrich, S. De La Peña, A.
author_sort	Willis, B.A.
title	Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
title_short	Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
title_full	Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
title_fullStr	Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
title_full_unstemmed	Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
title_sort	semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/112067
_version_	1821181843875037184

Semagacestat pharmacokinetics are not significantly affected by formulation, food, or time of dosing in healthy participants

Similar Items